As the global economy recovers in 2021 and the supply of the industrial chain improves, the Human Milk Oligosaccharides (HMO) market will undergo major changes. According to the latest research, the market size of the Human Milk Oligosaccharides (HMO) industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Human Milk Oligosaccharides (HMO) industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Human Milk Oligosaccharides (HMO) market during the next few years. The global Human Milk Oligosaccharides (HMO) market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The Human Milk Oligosaccharides (HMO) market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Highlights-Players
Major Players in Human Milk Oligosaccharides (HMO) market are:
DSM
BASF SE
CHR Hansen Holding A/S
DUPONT
Nestle
Inbiose N.V
Gnubiotics Sciences S.A
Abbott Laboratories
Royal Friesland Campina N.V
Elicityl S.A
Dextra Laboratories
Highlights-Types
Most important types of Human Milk Oligosaccharides (HMO) products covered in this report are:
Neutral
Acidic
Application listHighlights-Application
Most widely Application of Human Milk Oligosaccharides (HMO) market covered in this report are:
Infant Formula
Functional Food & Beverages
Food Supplements
Other Applications
Table of Content
1 Human Milk Oligosaccharides (HMO) Market Scope Analysis Introduction
1.1 Product Definition and Scope Introduction of Human Milk Oligosaccharides (HMO)
1.2 Market by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Typ
1.2.2 Global Human Milk Oligosaccharides (HMO) Market Type Definitio
1.3 Market by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application
1.3.2 Global Human Milk Oligosaccharides (HMO) Market Application Definition
1.4 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
1.4.1 Global Human Milk Oligosaccharides (HMO) Revenue 2017-2028
1.4.2 Global Human Milk Oligosaccharides (HMO) Sales 2017-2028
1.4.3 Human Milk Oligosaccharides (HMO) Market Size by Region: 2017 Versus 2022 Versus 2028
2 Analysis of Key Market Players
2.1 Global Human Milk Oligosaccharides (HMO) Sales by Players
2.1.1 Global Top Human Milk Oligosaccharides (HMO) Players by Sales (2017-2022)
2.1.2 Global Top Human Milk Oligosaccharides (HMO) Players Market Share by Sales (2017-2022)
2.1.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Sales in 2020
2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Players
2.2.1 Global Top Human Milk Oligosaccharides (HMO) Players by Revenue (2017-2022)
2.2.2 Global Top Human Milk Oligosaccharides (HMO) Players Market Share by Revenue (2017-2022)
2.2.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2020
2.3 Mergers & Acquisitions, Expansion Plans
2.4 DSM
2.4.1 DSM Corporation Information
2.4.2 DSM Overview
2.4.3 DSM Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.4.4 DSM Human Milk Oligosaccharides (HMO) Product Description
2.4.5 DSM Human Milk Oligosaccharides (HMO) Related Developments
2.5 BASF SE
2.5.1 BASF SE Corporation Information
2.5.2 BASF SE Overview
2.5.3 BASF SE Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.5.4 BASF SE Human Milk Oligosaccharides (HMO) Product Description
2.5.5 BASF SE Human Milk Oligosaccharides (HMO) Related Developments
2.6 CHR Hansen Holding A/S
2.6.1 CHR Hansen Holding A/S Corporation Information
2.6.2 CHR Hansen Holding A/S Overview
2.6.3 CHR Hansen Holding A/S Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.6.4 CHR Hansen Holding A/S Human Milk Oligosaccharides (HMO) Product Description
2.6.5 CHR Hansen Holding A/S Human Milk Oligosaccharides (HMO) Related Developments
2.7 DUPONT
2.7.1 DUPONT Corporation Information
2.7.2 DUPONT Overview
2.7.3 DUPONT Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.7.4 DUPONT Human Milk Oligosaccharides (HMO) Product Description
2.7.5 DUPONT Human Milk Oligosaccharides (HMO) Related Developments
2.8 Nestle
2.8.1 Nestle Corporation Information
2.8.2 Nestle Overview
2.8.3 Nestle Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.8.4 Nestle Human Milk Oligosaccharides (HMO) Product Description
2.8.5 Nestle Human Milk Oligosaccharides (HMO) Related Developments
2.9 Inbiose N.V
2.9.1 Inbiose N.V Corporation Information
2.9.2 Inbiose N.V Overview
2.9.3 Inbiose N.V Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.9.4 Inbiose N.V Human Milk Oligosaccharides (HMO) Product Description
2.9.5 Inbiose N.V Human Milk Oligosaccharides (HMO) Related Developments
2.10 Gnubiotics Sciences S.A
2.10.1 Gnubiotics Sciences S.A Corporation Information
2.10.2 Gnubiotics Sciences S.A Overview
2.10.3 Gnubiotics Sciences S.A Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.10.4 Gnubiotics Sciences S.A Human Milk Oligosaccharides (HMO) Product Description
2.10.5 Gnubiotics Sciences S.A Human Milk Oligosaccharides (HMO) Related Developments
2.11 Abbott Laboratories
2.11.1 Abbott Laboratories Corporation Information
2.11.2 Abbott Laboratories Overview
2.11.3 Abbott Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.11.4 Abbott Laboratories Human Milk Oligosaccharides (HMO) Product Description
2.11.5 Abbott Laboratories Human Milk Oligosaccharides (HMO) Related Developments
2.12 Royal Friesland Campina N.V
2.12.1 Royal Friesland Campina N.V Corporation Information
2.12.2 Royal Friesland Campina N.V Overview
2.12.3 Royal Friesland Campina N.V Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.12.4 Royal Friesland Campina N.V Human Milk Oligosaccharides (HMO) Product Description
2.12.5 Royal Friesland Campina N.V Human Milk Oligosaccharides (HMO) Related Developments
2.13 Elicityl S.A
2.13.1 Elicityl S.A Corporation Information
2.13.2 Elicityl S.A Overview
2.13.3 Elicityl S.A Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.13.4 Elicityl S.A Human Milk Oligosaccharides (HMO) Product Description
2.13.5 Elicityl S.A Human Milk Oligosaccharides (HMO) Related Developments
2.14 Dextra Laboratories
2.14.1 Dextra Laboratories Corporation Information
2.14.2 Dextra Laboratories Overview
2.14.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
2.14.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Description
2.14.5 Dextra Laboratories Human Milk Oligosaccharides (HMO) Related Developments
3 Human Milk Oligosaccharides (HMO) Historical and Forecast Market Size by Region
3.1 Global Human Milk Oligosaccharides (HMO) Historical and Forecast Sales Market Size by Region
3.2 Global Human Milk Oligosaccharides (HMO) Historical and Forecast Revenue Market Size by Region
3.3 {xx} Historical and Forecast Market Size by Country
3.3.1 {xx} Historical and Forecast Sales Market Size by Country (2017-2028)
3.3.2 {xx} Historical and Forecast Revenue Market Size by Country (2017-2028)
4 Market Size by Type
4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type
4.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Type (2017-2022)
4.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type
4.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Type (2017-2022)
4.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
4.3 Global Human Milk Oligosaccharides (HMO) Price by Type
4.3.1 Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022)
4.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application
5.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Application (2017-2022)
5.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application
5.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Application (2017-2022)
5.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Application
5.3.1 Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022)
5.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028)
6 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis
6.1 Human Milk Oligosaccharides (HMO) Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Key Suppliers of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
6.4 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
7 Marketing Channel, Distributors and Customers
7.1 Marketing Channel
7.2 Human Milk Oligosaccharides (HMO) Distributors List
7.3 Human Milk Oligosaccharides (HMO) Customers
8 Human Milk Oligosaccharides (HMO) Market Dynamics
8.1 Human Milk Oligosaccharides (HMO) Industry Trends
8.2 Human Milk Oligosaccharides (HMO) Growth Drivers
8.3 Human Milk Oligosaccharides (HMO) Market Challenges
8.4 Human Milk Oligosaccharides (HMO) Market Restraints
9 Summary of research findings
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.2.3 Legal Disclaimer
DSM
BASF SE
CHR Hansen Holding A/S
DUPONT
Nestle
Inbiose N.V
Gnubiotics Sciences S.A
Abbott Laboratories
Royal Friesland Campina N.V
Elicityl S.A
Dextra Laboratories
*If Applicable.